ADM
47
2
APA
53
5
NVDA
54
5
ED
37
-6
APD
45
-2
AVY
47
-7
MPC
38
2
ACN
56
2
CMI
71
2
STI
18
11
KO
44
-2
MRK
63
3
AME
72
6
ADT
50
2
HRL
23
-12
NWS
60
2
AKAM
64
2
ETN
55
2
CFG
95
2
TAP
29
-11
ADM
47
2
APA
53
5
NVDA
54
5
ED
37
-6
APD
45
-2
AVY
47
-7
MPC
38
2
ACN
56
2
CMI
71
2
STI
18
11
KO
44
-2
MRK
63
3
AME
72
6
ADT
50
2
HRL
23
-12
NWS
60
2
AKAM
64
2
ETN
55
2
CFG
95
2
TAP
29
-11
Financhill
Back

Berkshire Hathaway, Inc. Vs. Apellis Pharmaceuticals, Inc. Industry Stock Comparison

Sell
42

BRK.A
Berkshire Hathaway, Inc.

Last Price:
$743,780.49
Seasonality Move:
6.26%
Buy
56

APLS
Apellis Pharmaceuticals, Inc.

Last Price:
$24.66
Seasonality Move:
7.92%
Sell
42
Berkshire Hathaway, Inc. (BRK.A) is a Sell

Is Berkshire Hathaway, Inc. a Buy, Sell or Hold?

  • The current Berkshire Hathaway, Inc. [BRK.A] share price is $745,600.00. The Score for BRK.A is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • BRK.A is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Apellis Pharmaceuticals, Inc. (APLS) is a Buy

Is Apellis Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals, Inc. [APLS] share price is $24.65. The Score for APLS is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BRK.A Stock Price Chart

What is Berkshire Hathaway, Inc.'s stock price today?

  • The Berkshire Hathaway, Inc. share price today is $745,600.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BRK.A is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals, Inc.'s stock price today?

BRK.A Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 322.91 Buy
Relative Strength Index (14 RSI): 46.68 Sell
Chaikin Money Flow: -576 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (754577.54 - 754593.54) Sell
Bollinger Bands (100): (739733.08 - 739767.08) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.85 Buy
Relative Strength Index (14 RSI): 60.12 Buy
Chaikin Money Flow: -939265 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.22 - 24.44) Buy
Bollinger Bands (100): (21.29 - 27.05) Buy

BRK.A Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 749019.12 Sell
20-day SMA: 754133.26 Sell
50-day SMA: 745400.18 Buy
200-day SMA: 747378.81 Sell
8-day EMA: 750636.52 Sell
20-day EMA: 751064.02 Sell
50-day EMA: 747824.77 Sell
200-day EMA: 734877.67 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.88 Sell
20-day SMA: 22.96 Buy
50-day SMA: 23.11 Buy
200-day SMA: 21.9 Buy
8-day EMA: 24.53 Buy
20-day EMA: 23.51 Buy
50-day EMA: 23.11 Buy
200-day EMA: 24.27 Buy

Berkshire Hathaway, Inc. Earnings Growth & BRK.A Earnings Dates

  • Analysts estimate an earnings increase this quarter of $299.76 per share, a decrease next quarter of $0.00 per share, an increase this year of $2,675.77 per share, and an increase next year of $3,470.08 per share.

Apellis Pharmaceuticals, Inc. Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.00 per share, and a decrease next year of $1.44 per share.

Berkshire Hathaway, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):